Why Koninklijke Philips (PHG) Stock Continues To Rise On Monday

NEW YORK (TheStreet) -- Shares of Koninklijke Philips (PHG) are higher by 4% to $37.69 on heavy volume in early afternoon trading as the stock continues a gain it started in pre-market trading today.

The Dutch lighting and healthcare company announced its plan to merge its lighting components businesses into a separate unit worth up to $2.7 billion, which could then be spun-off, Reuters reports.

The merger is part of the company's plan to refocus its business strategy on healthcare and high-end lighting systems.

Must Read: Warren Buffett's 25 Favorite Stocks


Separately, TheStreet Ratings team rates KONINKLIJKE PHILIPS NV as a Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:

"We rate KONINKLIJKE PHILIPS NV (PHG) a HOLD. The primary factors that have impacted our rating are mixed some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

  • PHG's revenue growth has slightly outpaced the industry average of 0.6%. Since the same quarter one year prior, revenues slightly increased by 2.6%. This growth in revenue does not appear to have trickled down to the company's bottom line, displaying stagnant earnings per share.
  • The current debt-to-equity ratio, 0.34, is low and is below the industry average, implying that there has been successful management of debt levels. Although the company had a strong debt-to-equity ratio, its quick ratio of 0.78 is somewhat weak and could be cause for future problems.
  • Compared to where it was 12 months ago, the stock is up, but it has so far lagged the appreciation in the S&P 500. We feel that the combination of its price rise over the last year and its current price-to-earnings ratio relative to its industry tend to reduce its upside potential.
  • The change in net income from the same quarter one year ago has exceeded that of the Industrial Conglomerates industry average, but is less than that of the S&P 500. The net income has decreased by 7.8% when compared to the same quarter one year ago, dropping from $206.34 million to $190.12 million.
  • You can view the full analysis from the report here: PHG Ratings Report
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

EY's Greene Sees More Med Tech, CRO Deals Ahead

Philips: Diagnostics Are Positive

5 Things You Must Know Before the Market Opens Wednesday

Philips Buys Medical Device Maker Spectranetics Corp.; Deal Has Enterprise Value of $2.15 Billion